ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

10 Fibro-Friendly Foods with a Bonus: Beautiful Skin

Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant...

Clary Sage Oil May Be Pricey, but Its Benefits Are Priceless

Pumpkin Pie Turmeric Breakfast Smoothie - Vegan + Gluten-Free

Component of red wine, grapes can help to reduce inflammation, study finds

Poly MVA: A Novel Therapy for Increasing Energy, Repairing DNA, and Promoting Overall Health

Vitamin D supplementation extends life in mouse model of Huntington's disease

Omega-3 fatty acid stops known trigger of lupus

Conquer Your Email Inbox, Increase Productivity and Reduce Stress

The Significance of Selenium

Print Page
Email Article

Study Identifies Three Distinct Subgroups of Fibromyalgia

  [ 842 votes ]   [ Discuss This Article ] • October 22, 2003

By Mindy Hung

Oct. 3, 2003 — Researchers have identified three distinct subgroups of patients with fibromyalgia (FM), according to results published in the October issue of Arthritis & Rheumatism.

"There appears to be a group of fibromyalgia patients who exhibit extreme tenderness but lack any associated psychological/cognitive factors, an intermediate group who display moderate tenderness and have normal mood, and a group in whom mood and cognitive factors may be significantly influencing the symptom report," write Thorsten Giesecke, MD, and colleagues from the University of Michigan, in Ann Arbor.

"Previous attempts at identifying subsets have been based solely on psychological and cognitive features. In this study, we attempt to identify patient subsets by incorporating these features as well as the degree of hyperalgesia/tenderness, which is a key neurobiologic feature of this disease," they add.

Investigators recruited and screened 117 patients (102 women and 15 men), ages 18 to 60 years, who met the 1990 American College of Rheumatology criteria for the classification of FM.

Researchers excluded those with severe physical impairment; medical conditions capable of causing patients' symptoms; cardiopulmonary disorders; uncontrolled endocrine or allergic disorders; malignancy; severe psychiatric illness; factors known to affect the hypothalamic-pituitary-adrenal axis (such as cigarette smoking or high daily caffeine intake); and usage of medications other than as-needed analgesics and appropriate dosages of thyroid hormone.

Subjects taking part in the two-day study protocol were asked to discontinue intake of antidepressants within one week prior to the study, and they were allowed to take nonsteroidal anti-inflammatory drugs until three days before the trial.

On the first day of study, patients completed self-report questionnaires from several domains consisting of mood, evaluated by the Center for Epidemiologic Studies Depression Scale and the State-Trait Personality Inventory; and cognition, evaluated by the catastrophic and control of pain subscales of the Coping Strategies Questionnaire. On the second day of the study, investigators tested for hyperalgesia/tenderness by dolorimetry and random pressure-pain applied at suprathreshold values.

All screened patients completed the study protocol; however, investigators obtained complete data on 97 of the 117 patients (85 women [87.6%] and 12 men [12.4%]).

Cluster analytic procedures revealed three subgroups of FM patients. Multivariate analysis of variance (ANOVA) confirmed that each variable was differentiated by the cluster solution (Wilks' [degrees of freedom, 6,89] = 0.123; P < .0001), with univariate ANOVAs also indicating significant differences (all P < .05).

The largest subgroup, which consisted of 55 patients (57%), showed moderate mood rating, moderate levels of catastrophizing and perceived control over pain, and low levels of tenderness. A second subgroup of 31 patients (32%) demonstrated significantly elevated values on the mood assessments, the highest values on the catastrophizing subscale, the lowest values for perceived control over pain, and high levels of tenderness.

The final group, of 16 patients (16%), displayed normal mood ratings, low levels of catastrophizing, the highest level of perceived control over pain, and extreme tenderness on evoked-pain testing.

"It might be expected that cluster 1, in which patients had moderate mood difficulties and already had very adaptive cognitive factors may be less likely to need or respond to cognitive behavioral approaches, whereas cluster 2, in which patients had extremely high levels of distress, might benefit most from this type of program," investigators write.

"Cluster 3 may possibly respond best to symptom-based pharmacologic therapy, including antidepressant agents with analgesic properties. Further studies need to replicate these findings, and additional testing should be done to determine whether these FM subgroupings can, in fact, be used to identify optimal treatments," they add.
This research was supported by a Department of Army grant, and by the National Institutes of Health.

Reference: Arthritis Rheum. 2003;48:2916-2922
Reviewed by Gary D. Vogin, MD
Source: Medscape.

Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Energy NADH™ 12.5mg Optimized Curcumin Longvida®

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Natural Pain Relief Supplements

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Looking for Energy? Turn to Plants. Looking for Energy? Turn to Plants.
The Big Blue Fish that Helps Chase the Blues Away The Big Blue Fish that Helps Chase the Blues Away
Nutrients to Combat the Modern Stress Epidemic Nutrients to Combat the Modern Stress Epidemic
Eating Fat is Good... Maybe... Could Be... Sometimes Eating Fat is Good... Maybe... Could Be... Sometimes
Could a B-12 Deficiency Be Causing Your Symptoms? Could a B-12 Deficiency Be Causing Your Symptoms?

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map